![Ian Taylor](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ian Taylor
No open positions remaining
Net worth: 1 M $ as of 2026-05-30
Profile
Presently, Ian Taylor is Chief Scientific Officer of Arvinas, Inc. In the past he occupied the position of Senior Director-Translational Oncology at Pfizer Inc. and Vice President-Cancer Biology at Bayer HealthCare. Dr. Taylor received an undergraduate degree from Bowdoin College and an undergraduate degree from Harvard University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ARVINAS, INC. 0.22% | 2026-03-30 | 138,876 ( 0.22% ) | 1 M $ | 2026-05-30 |
Former positions of Ian Taylor
| Companies | Position | End |
|---|---|---|
| ARVINAS, INC. | Chief Tech/Sci/R&D Officer | 2025-06-05 |
| PFIZER INC. | Corporate Officer/Principal | 2016-04-30 |
Bayer HealthCare
 Bayer HealthCare Medical/Nursing ServicesHealth Services Provides medical care, and animal health care services | Corporate Officer/Principal | - |
Training of Ian Taylor
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
84
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bowdoin College
 Bowdoin College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bayer HealthCare
Bayer HealthCare Medical/Nursing ServicesHealth Services Provides medical care, and animal health care services | Health Services |
Arvinas, Inc.
 Arvinas, Inc. BiotechnologyHealth Technology Engages in discovery, development and commercialization of therapies to degrade disease-causing proteins | Health Technology |
- Stock Market
- Insiders
- Ian Taylor
